The diuretic chlorthalidone normalizes baroreceptor and Bezold-Jarisch reflexes in DOCA-salt hypertensive rats.
The contributions of arterial baroreceptor and Bezold-Jarisch reflexes, and atrial natriuretic factor (ANF) to the anti-hypertensive effect of the diuretic chlorthalidone were investigated in rats with deoxycorticosterone acetate (DOCA)-salt-induced hypertension. Chlorthalidone (8 mg rat(-1)day(-1)added to food) was given to one group during all 20 days of DOCA (8 mg kg(-1)s.c. twice per week) administration (preventive regimen) and, to another group, 20 days after DOCA treatment was initiated until the 40th day (therapeutic regimen). DOCA caused a significant increase in mean arterial pressure, reduced arterial baroreflex, and increased both the Bezold-Jarisch reflex and pro-ANF converting enzyme activity. Chlorthalidone reversed or prevented the DOCA-salt-induced hypertension, which was accompanied by the normalization of both the arterial baroreflex and the Bezold-Jarisch reflex. Additionally, both preventive and therapeutic regimens with chlorthalidone did cause normalization of the plasma sodium concentration and pro-ANF converting enzyme activity in the left atrium that follows DOCA-salt hypertension. Although it is difficult to determine the relative importance of each of the above regulatory mechanisms altered by chlorthalidone treatment, these data indicate that they may account for the prevention or decrease of DOCA-salt-induced hypertension in rats.
Bissoli
N S
NS
Department of Physiological Sciences, Biomedical Center, Federal University of Espirito Santo, UFES, Av. Marechal Campos 1468, Vitoria, ES, 29040-090, Brazil.
Cicilini
M A
MA
Vasquez
E C
EC
Cabral
A M
AM
D000818:Animals; D009320:Atrial Natriuretic Factor / Q000378:metabolism; D017704:Baroreflex / Q000187:drug effects*; D001645:Biguanides / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D002752:Chlorthalidone / Q000494:pharmacology*; D003900:Desoxycorticosterone; D004232:Diuretics / Q000494:pharmacology*; D006339:Heart Rate / Q000187:drug effects; D006973:Hypertension / Q000139:chemically induced / Q000503:physiopathology*; D008297:Male; D009206:Myocardium / Q000378:metabolism; D011188:Potassium / Q000378:metabolism; D011311:Pressoreceptors / Q000187:drug effects*; D051381:Rats; D017208:Rats, Wistar; D017366:Serotonin Receptor Agonists / Q000494:pharmacology; D012964:Sodium / Q000378:metabolism
D001645:Biguanides; D004232:Diuretics; D017366:Serotonin Receptor Agonists; D003900:Desoxycorticosterone; D009320:Atrial Natriuretic Factor; D012964:Sodium; D002752:Chlorthalidone; D011188:Potassium; C008846:phenyl biguanide